Status:

COMPLETED

Tai Chi Training for Children With ADHD

Lead Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Conditions:

ADHD

Eligibility:

All Genders

8-12 years

Phase:

NA

Brief Summary

Attention Deficit Hyperactivity Disorder (ADHD) has tremendous individual and societal impact, and the effectiveness of current standard treatments is limited. We examine a novel treatment that could ...

Detailed Description

Persistent poor outcomes for individuals with ADHD make it imperative to explore intervention approaches beyond medication, particularly interventions that could provide sustained improvements in cont...

Eligibility Criteria

Inclusion

  • Children must meet diagnostic criteria for ADHD on the Kiddie Schedule for Affective Disorders and Schizophrenia
  • Comorbid oppositional defiant disorder (ODD) and simple phobias are permitted
  • right handed
  • Stimulant or no medication

Exclusion

  • left handed
  • diagnosis of Intellectual Disability, Developmental Language Disorder, Reading Disability, or Autism (screened for using the Social Competence Questionnaire (SCQ)
  • neurologic disorder (e.g., epilepsy, cerebral palsy, traumatic brain injury, Tourette Syndrome)
  • documented hearing impairment ≥ 25 dB (decibel) loss in either ear.
  • history of speech/language disorder or a Reading Disability (RD)
  • a Full Scale IQ (Intelligence Quotient) score on the WISC-IV (Wechsler Intelligence Scale for Children) below 80
  • a standard score below 85 on the Word Reading Subtest, regardless of IQ score
  • foster care
  • previous participation in Tai Chi Training
  • parent and child report signs of puberty above Tanners-2
  • Female participants will be excluded if they are pregnant or may be pregnant
  • Non-stimulant psychoactive medications (e.g., atomoxetine, clonidine, tricyclic antidepressants, selective serotonin re-uptake inhibitors)

Key Trial Info

Start Date :

July 17 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2020

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT02234557

Start Date

July 17 2014

End Date

March 15 2020

Last Update

November 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LEAP Facility at Kennedy Krieger Institute

Baltimore, Maryland, United States, 21211